Latest Capital Raises News

Noronex Limited has accelerated its drilling programs across key Kalahari Copper Belt projects, secured a strategic placement, and agreed to sell its Witvlei asset, positioning itself for uranium exploration in Namibia.

EQ Resources Limited reported record production and processing at its Barruecopardo and Mt Carbine tungsten mines in Q2 FY2026, supported by strong tungsten prices and a successful A$34 million equity raising that strengthened its balance sheet.

Metallium Limited has raised A$75 million in a strategic capital round led by U.S. institutional investors, accelerating its commercial operations in Texas and setting the stage for a NASDAQ listing later this year.

Breakthrough Minerals has entered a conditional agreement to acquire a major copper-gold project in North Queensland, backed by a successful A$8.15 million capital raise. The acquisition and fresh funding position the company for an aggressive exploration campaign in the Mt Isa region.

Star Minerals has received mining approval for its Tumblegum South Gold Project and commenced grade control drilling, setting the stage for production in early 2026 amid rising gold prices.

Paladin Energy reports a strong production ramp-up at its Langer Heinrich Mine and confirms robust progress on the Patterson Lake South project, supported by a strengthened balance sheet and a positive uranium market outlook.

Pengana International Equities has raised its fully franked quarterly dividend to 1.4 cents per share, reflecting confidence in its earnings. Meanwhile, the company’s Independent Board Committee continues to evaluate strategic options, promising an update by February’s end.

Paladin Energy reports a 16% rise in uranium production at Langer Heinrich Mine, with strong sales and a fortified balance sheet positioning the company for growth. Exploration advances in Canada and leadership changes signal a strategic push forward.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

Astral Resources reports strong high-grade gold assay results from recent drilling at its Feysville and Mandilla projects in Western Australia, highlighting significant extensions beyond current resource models and advancing development prospects.

Anteris Technologies has launched a $200 million public offering alongside a $90 million strategic investment from Medtronic, aiming to accelerate its DurAVR heart valve clinical trials and manufacturing expansion.

VHM Limited has made significant strides in developing its Goschen Rare Earths and Mineral Sands Project, securing substantial funding and critical regulatory approvals while expanding its resource base.